Virax Biolabs Group Stock (NASDAQ:VRAX)
Previous Close
$2.89
52W Range
$2.50 - $25.00
50D Avg
$4.38
200D Avg
$7.06
Market Cap
$546.81K
Avg Vol (3M)
$2.22M
Beta
1.33
Div Yield
-
VRAX Company Profile
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.